Radiological evidence of nonalcoholic fatty liver disease in familial combined hyperlipidemia

被引:20
作者
de Bruin, TWA
Georgieva, AM
Brouwers, MCGJ
Heitink, MV
van der Kallen, CJH
van Greevenbroek, MMJ
机构
[1] Cardiovasc. Res. Inst. Maastricht, Department of Medicine, University of Maastricht, Maastricht
[2] Dept. of Int. Med. and Endocrinology, Academic Hospital Maastricht, University of Maastricht, 6202 AZ Maastricht
关键词
D O I
10.1016/j.amjmed.2003.12.031
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
[No abstract available]
引用
收藏
页码:847 / 849
页数:3
相关论文
共 12 条
[1]
Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[2]
Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemia [J].
Eurlings, PMH ;
van der Kallen, CJH ;
Geurts, JMW ;
Flavell, DM ;
de Bruin, TWA .
MOLECULAR GENETICS AND METABOLISM, 2002, 77 (04) :274-281
[3]
Variants in the PPARγ gene affect fatty acid and glycerol metabolism in familial combined hyperlipidemia [J].
Eurlings, PMH ;
van der Kallen, CJH ;
Vermeulen, VMMJ ;
de Bruin, TWA .
MOLECULAR GENETICS AND METABOLISM, 2003, 80 (03) :296-301
[4]
GRUNDY SM, 1987, ARTERIOSCLEROSIS, V7, P203
[5]
The metabolic abnormalities associated with non-alcoholic fatty liver disease [J].
Haque, M ;
Sanyal, AJ .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2002, 16 (05) :709-731
[6]
COMPARISON OF LIVER HISTOLOGY WITH ULTRASONOGRAPHY IN ASSESSING DIFFUSE PARENCHYMAL LIVER-DISEASE [J].
JOSEPH, AEA ;
SAVERYMUTTU, SH ;
ALSAM, S ;
COOK, MG ;
MAXWELL, JD .
CLINICAL RADIOLOGY, 1991, 43 (01) :26-31
[7]
Familial dyslipidemic hypertension syndrome: Familial combined hyperlipidemia, and the role of abdominal fat mass [J].
Keulen, ETP ;
Voors-Pette, C ;
de Bruin, TWA .
AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (04) :357-363
[8]
Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes [J].
Lewis, GF ;
Carpentier, A ;
Adeli, K ;
Giacca, A .
ENDOCRINE REVIEWS, 2002, 23 (02) :201-229
[9]
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone [J].
Neuschwander-Tetri, BA ;
Brunt, EM ;
Wehmeier, KR ;
Oliver, D ;
Bacon, BR .
HEPATOLOGY, 2003, 38 (04) :1008-1017
[10]
Peroxisome-proliferator-activated receptor-α (PPARα) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin [J].
Sugden, MC ;
Bulmer, K ;
Gibbons, GF ;
Knight, BL ;
Holness, MJ .
BIOCHEMICAL JOURNAL, 2002, 364 :361-368